Clinical Oncology
Volume 18, Issue 6 , Pages 453-458 , August 2006

Pre-treatment Haemoglobin Levels and the Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer

  • M.J. Beresford

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK
    • Corresponding Author InformationAuthor for correspondence: Mark Beresford, Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, Middlesex HA6 2RN, UK. Tel: +44-1923-826111.
    • ,
  • R. Burcombe

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK
    • ,
  • M.-L. Ah-See

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK
    • ,
  • D. Stott

      Affiliations

    • Health Research Development and Support Unit (HRDSU), University of Hertfordshire, Hatfield, UK
    • ,
  • A. Makris

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK

Received 13 December 2005 ,Revised 22 March 2006 ,Accepted 10 April 2006.

References 

  1. Evans JC, Bergsjo P. The influence of anemia on the results of radiotherapy in carcinoma of the cervix. Radiology. 1965;84:709–717
  2. Quilty PM, Kerr GR, Duncan W. Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol. 1986;7:311–321
  3. Fein DA, Lee WR, Hanlon AL, et al. Pretreatment hemoglobin level influences local control and survival of T1–T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol. 1995;13:2077–2083
  4. Prosnitz RG, Yao B, Farrell CL, et al. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 2005;61:1087–1095
  5. Molls M, Stadler P, Becker A, et al. Relevance of oxygen in radiation oncology. Mechanisms of action, correlation to low hemoglobin levels. Strahlenther Onkol. 1998;174(suppl 4):13–16
  6. Dunst J, Pigorsch S, Hansgen G, et al. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?. Strahlenther Onkol. 1999;175:93–96
  7. Kovacs R, Wilhelm R, Heinrichson D. Survival of exclusively irradiated patients with NSCLC. Significance of pretherapeutic hemoglobin levels. Strahlenther Onkol. 1998;174:128–132
  8. Sibtain A, Saunders MI, Bentzen SM, Hoskin PJ. Pre-treatment haemoglobin concentration in accelerated and conventional radiotherapy for non-small cell lung carcinoma. Clin Oncol (R Coll Radiol). 2004;16:58–62
  9. Kirshner J, Hatch M, Hennessy DD, et al. Anemia in stage II and III breast cancer patients treated with adjuvant doxorubicin and cyclophosphamide chemotherapy. Oncologist. 2004;9:25–32
  10. Bottini A, Berruti A, Brizzi MP, et al. Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer. Br J Cancer. 2003;89:977–982
  11. Leonard RC, Untch M, Von Koch F. Management of anaemia in patients with breast cancer: role of epoetin. Ann Oncol. 2005;16:817–824
  12. Lind M, Vernon C, Cruickshank D, et al. The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer. 2002;86:1243–1249
  13. Chang J, Couture F, Young S, et al. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy. J Clin Oncol. 2005;23:2597–2605
  14. Untch M, Kahlert S, Thomssen C, et al. Therapy-induced anaemia with dose-intensified chemotherapy — clinical relevance in the adjuvant treatment of breast cancer patients. 22nd Annual San Antonio Breast Cancer Symposium. Breast Cancer Res Treat. 1999;57:46
  15. Kuerer HM, Newman LA, Buzdar AU, et al. Pathologic tumour response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. Cancer J Sci Am. 1998;4:230–236
  16. Ogston KN, Miller ID, Payne S, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast. 2003;12:320–327
  17. Herrada J, Iyer RB, Atkinson EN, et al. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res. 1997;3:1565–1569
  18. Helvie MA, Joynt LK, Cody RL, et al. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology. 1996;198:327–332
  19. Peters-Engl C, Cassik P, Schmidt I, et al. Impact of haemoglobin levels during adjuvant chemotherapy on the survival of patients with primary breast cancer. Acta Oncol. 2005;44:129–133
  20. Henke M, Sindlinger F, Ikenberg H, et al. Blood hemoglobin level and treatment outcome of early breast cancer. Strahlenther Onkol. 2004;180:45–51

PII: S0936-6555(06)00161-0

doi: 10.1016/j.clon.2006.04.006

Clinical Oncology
Volume 18, Issue 6 , Pages 453-458 , August 2006

Article Tools

* Image Usage & Resolution